NCT05994404

Brief Summary

The purpose of the study is to determine the cost-effectiveness of different surgical strategies to treat cervical spondylotic myelopathy. The study will use data generated from the CSM-S Trial (NCT02076113).

  1. 1.To determine if laminoplasty is more cost-effective compared to dorsal fusion or ventral fusion surgery.
  2. 2.To determine the relative cost-effectiveness between anterior cervical discectomy and fusion (ACDF), posterior instrumented cervical fusion (PCF), and cervical laminoplasty.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
269

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2014

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
4.3 years until next milestone

First Submitted

Initial submission to the registry

July 28, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 16, 2023

Completed
Last Updated

August 16, 2023

Status Verified

July 1, 2023

Enrollment Period

4 years

First QC Date

July 28, 2023

Last Update Submit

August 11, 2023

Conditions

Keywords

cost-effectivenesscervical spondylotic myelopathyhealth resource utilizationspinal fusionlaminoplasty

Outcome Measures

Primary Outcomes (1)

  • Total Health Costs - Societal Perspective

    Index hospitalization costs+one-year all cause costs+loss of productivity costs

    5 years

Secondary Outcomes (3)

  • Index Hospitalization Costs

    30 days

  • 1-Year all-cause health costs

    1 year

  • Loss of productivity costs

    5 years

Study Arms (3)

Anterior Cervical Discectomy and Fusion

Ventral decompression and fusion was performed using multi-level discectomy (including partial or single level corpectomy) with fusion and plating. Allograft was used at each disc space and all compressive osteophytes were removed using the operating microscope. Plate fixation was done with rigid, semi-constrained, or dynamic titanium plates to optimize fusion and minimize complications.

Procedure: ACDF

Posterior Instrumented Cervical Fusion

Dorsal decompression and instrumented fusion was performed using midline cervical laminoectom with the application of lateral mass screws and rods for rigid fixation. Local bone was used along with allograft to promote a lateral mass fusion.

Procedure: Posterior Cervical Fusion

Laminoplasty

Laminoplasty was performed using an open-door approach with the application of plates and screws at each treated level. Ceramic or allograft laminar spacers (surgeon's choice) were used with titanium plates and screws to expand the spinal canal diameter.

Procedure: Cervical Laminoplasty

Interventions

ACDFPROCEDURE
Anterior Cervical Discectomy and Fusion
Posterior Instrumented Cervical Fusion
Laminoplasty

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population consists of patients with multi-level cervical spondylotic myelopathy without kyphosis and who satisfied clinical equipoise criteria (ventral vs. dorsal approach) as judged by a panel of at least 15 spine experts.

You may qualify if:

  • Patients with Cervical Myelopathy (\> or equal to 2 levels of spinal cord compression from C3 to C7) with 2 or more of the following symptoms/ signs: clumsy hands, gait disturbance, hyperreflexia, upgoing toes, bladder dysfunction.

You may not qualify if:

  • C2-C7 kyphosis\>5 degrees (measured in standing extension radiograph)
  • segmental kyphotic deformity (defined by greater than 3 osteophytes extending dorsal to a C2-C7 dorsal-caudal line measured on cervical spine CT)
  • structurally significant ossification of the posterior longitudinal ligament (OPLL - measured on cervical spine CT)
  • previous cervical spine surgery, or significant active health-related co-morbidity (Anesthesia Class IV or higher)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Lahey Hospital & Medical Center

Burlington, Massachusetts, 01803, United States

Location

Mayo Clinic

Rochester, Minnesota, 55902, United States

Location

Related Publications (1)

  • Ghogawala Z, Terrin N, Dunbar MR, Breeze JL, Freund KM, Kanter AS, Mummaneni PV, Bisson EF, Barker FG 2nd, Schwartz JS, Harrop JS, Magge SN, Heary RF, Fehlings MG, Albert TJ, Arnold PM, Riew KD, Steinmetz MP, Wang MC, Whitmore RG, Heller JG, Benzel EC. Effect of Ventral vs Dorsal Spinal Surgery on Patient-Reported Physical Functioning in Patients With Cervical Spondylotic Myelopathy: A Randomized Clinical Trial. JAMA. 2021 Mar 9;325(10):942-951. doi: 10.1001/jama.2021.1233.

Study Officials

  • Zoher Ghogawala, MD

    Lahey Hospital & Medical Center

    STUDY DIRECTOR
  • Robert G. Whitmore, MD

    Lahey Hospital & Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2023

First Posted

August 16, 2023

Study Start

April 1, 2014

Primary Completion

March 30, 2018

Study Completion

April 1, 2019

Last Updated

August 16, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

De-identified data from the CSM-S trial including cost data will be available to other researchers who provide a valid study protocol.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Within 6 months of primary publication of the data and for 5 years thereafter
Access Criteria
Researchers with a clear and valid research protocol will be able to gain access to the data.

Locations